Founding CEO Tripp Higgins To Become Chairman of the Board of Directors, Supporting the Leadership Transition As Finkelmeier Puts Operational Structure in Place to Meet Growing Demand
PaceMate, the cardiac remote monitoring platform that leading healthcare providers trust, today announced the appointment of JR Finkelmeier as Chief Executive Officer (CEO). Finkelmeier joined PaceMate as Chief Commercial Officer in 2024, after years leading Philips’ multi-hundred-million-dollar ambulatory monitoring division. As CEO of PaceMate, he will lead the company through operational transformation in support of plans for significant commercial expansion. Finkelmeier succeeds founding CEO Tripp Higgins, who will become the Chairman of the Board of Directors.
Since its founding 10 years ago, PaceMate has achieved widespread adoption by healthcare providers like Duke Health, Advocate Health and many others. In 2024, PaceMate acquired Medtronic’s PaceArt Optima™ system, adding nearly 1,000 more clinic locations and making it the only company that can fully convert and transfer the full spectrum of in-person and historical PaceArt patient data. Now, with more than 2 million patients under management, and more health systems than ever looking to migrate legacy monitoring systems to the cloud, PaceMate is focused on pairing a decade of product innovation with the operational scale needed to meet the growing demands of modern cardiac care.
It’s against this backdrop that Finkelmeier sets out to significantly expand PaceMate’s operational readiness to scale delivery across a fast-growing customer base. To lay the foundation for this strategic transformation, Finkelmeier will look to his more than two decades of experience scaling high-growth healthcare and medical technology companies. Among his immediate priorities are meeting demand for the company's core platform, PaceMateLIVE, and continued investment in the company's AI-tech-enabled clinical capabilities and certified cardiac expertise.
“I’m honored to take on this role and continue building on the strong foundation Tripp has created,” said Finkelmeier. “PaceMate realized before anyone else that, with complex cardiac data spread across disparate systems, data gathering is at odds with delivering the best patient care. The company spent a decade building the ideal platform to solve this challenge. PaceMate’s original mission to improve outcomes through real-time cardiac monitoring is more vital now than ever. I look forward to leading the company forward as it delivers connected cardiac care to more providers and patients around the world.”
PaceMate was founded in 2015 by industry veterans Tripp Higgins, Jason Hale, Noemi Ray and Gabe Rosu, who saw firsthand the challenges clinicians face in managing the overwhelming volume and complexity of cardiac data. In response, they built what is now the industry’s most comprehensive end-to-end remote cardiac monitoring platform. That founding team remains fully in place today, with Higgins actively serving on the Board of Directors. He will directly support the leadership transition as JR Finkelmeier works to progress the company’s mission of transforming cardiac data management across healthcare systems (including hospitals, healthcare providers, clinics and physicians).
“From the beginning, our goal has been to build a platform that eliminates the unnecessary challenges created by traditional remote monitoring approaches, so clinicians can provide their patients with the best care possible,” said Tripp Higgins, Chairman of the Board and Co-founder of PaceMate. “We translated the real-world problems that care teams face into a platform that significantly streamlines their workflows, expedites time to clinical care and intelligently prioritizes patients. Now, JR brings the growth expertise necessary to take PaceMate to the next level, ensuring that our platform reaches its full potential.”
Since its founding, PaceMate’s innovation roadmap has been shaped by the clinicians and care teams who directly rely on it. As a result, the platform is uniquely designed to meet the real-world workflows and clinical demands of cardiac care. Under Finkelmeier’s leadership, the company will continue to evolve with the same customer-led focus, while building the infrastructure to support long-term growth.
About PaceMate
PaceMate® is the always-on cardiac remote monitoring and AI-enabled, intelligent data management platform that leading clinicians trust to automate workflows, prioritize critical patients and deliver better and faster care. The company’s cloud-based system enables care teams to manage cardiac device patients through a single, end-to-end platform that integrates with every major EHR and device vendor. With always up-to-date, comprehensive data, PaceMate delivers actionable insights for providers to optimize practice performance and drive better patient outcomes. PaceMate is helping integrated delivery networks (IDNs) and academic health systems, including Duke Health, Advocate Health and many others modernize and scale cardiac care delivery. The company is headquartered in Sarasota, Florida. Join us at PaceMate.com to see how together—we never miss a beat.®
View source version on businesswire.com: https://www.businesswire.com/news/home/20250605218840/en/
Contacts
Channel V Media
Kieran Powell
Kieran.Powell@channelvmedia.com
